Cambridge Cognition (LON:COG) Sets New 1-Year Low – Here’s Why

Cambridge Cognition Holdings Plc (LON:COG) reached a new 52-week low during mid-day trading on Tuesday. The company traded as low as GBX 26 and last traded at GBX 27.65, with a volume of 14,910 shares. The stock had previously closed at GBX 28.

Cambridge Cognition Trading Down 1.3%

The company has a 50 day simple moving average of GBX 28.51 and a two-hundred day simple moving average of GBX 33.93. The company has a debt-to-equity ratio of 10.91, a quick ratio of 0.96 and a current ratio of 0.41. The firm has a market cap of £14.93 million, a PE ratio of -8.92 and a beta of 0.81.

Cambridge Cognition (LON:COG) last announced its quarterly earnings data on Wednesday, September 16th. The company reported GBX (1.60) EPS for the quarter. Cambridge Cognition had a negative net margin of 13.86% and a negative return on equity of 54.17%. Analysts expect that Cambridge Cognition Holdings Plc will post 1.03 EPS for the current fiscal year.

About Cambridge Cognition

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.